Showing results (51-60 of 197) with videos related to

Sort By:
Pageof 20
Human Gene Therapy|July 15, 2010
Creating higher titer lentivirus with caffeineBrian L Ellis, Patrick Ryan Potts, Matthew H Porteus
Hematology/Oncology Clinics of North America|June 30, 2022
A Curative DNA Code for Hematopoietic Defects: Novel Cell Therapies for Monogenic Diseases of the Blood and Immune SystemMatthew H Porteus, Mara Pavel-Dinu, Sung-Yun Pai
Molecular Therapy. Nucleic Acids|April 25, 2013
Design and Development of Artificial Zinc Finger Transcription Factors and Zinc Finger Nucleases to the hTERT LocusKimberly A Wilson, Morgan L Chateau, Matthew H Porteus
Ugeskrift for Laeger|June 20, 2025
[CRISPR/Cas gene editing of haematopoietic stem cells for curing primary immunodeficiency]Rasmus O Bak, Mette Holm, Bjarne Møller, et al.
Molecular and Cellular Biology|May 2, 2003
Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaksMatthew H Porteus, Toni Cathomen, Matthew D Weitzman, et al.
Trends in Biotechnology|January 18, 2015
Quantifying on- and off-target genome editingAyal Hendel, Eli J Fine, Gang Bao, et al.
Nature Communications|September 8, 2019
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type INatalia Gomez-Ospina, Samantha G Scharenberg, Nathalie Mostrel, et al.
Genome Biology|June 3, 2014
Lentiviral and targeted cellular barcoding reveals ongoing clonal dynamics of cell lines in vitro and in vivoShaina N Porter, Lee C Baker, David Mittelman, et al.
RNA (New York, N.Y.)|December 20, 2012
Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitorsRasmus O Bak, Anne Kruse Hollensen, Maria Nascimento Primo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2024
Orthogonal transcriptional modulation and gene editing using multiple CRISPR-Cas systemsAmalie Dyrelund Broksø, Louise Bendixen, Simon Fammé, et al.
Pageof 20